α-Tocopherol modulates human umbilical vein endothelial cell expression of Cu/Zn superoxide dismutase and catalase and lipid peroxidation

Nutrition Research

Volumn 28, Issue 10, 2008, Pages 671-680

  Nakamura, Yukiko K ^a   Omaye, Stanley T ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

Tocopherol; Catalase; Endothelial cells; Human; Lipid peroxidation; NF B; PPAR ; SOD

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER;

ANTIOXIDANT ACTIVITY; ARTICLE; DNA BINDING; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MESSENGER RNA SYNTHESIS; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UMBILICAL VEIN;

ALPHA-TOCOPHEROL; CATALASE; CELLS, CULTURED; COPPER; ENDOTHELIAL CELLS; HUMANS; LIPID PEROXIDATION; NF-KAPPA B; OXIDATION-REDUCTION; PPAR GAMMA; RNA, MESSENGER; SUPEROXIDE DISMUTASE; UMBILICAL VEINS; ZINC;

EID: 53249144064     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2008.07.002     Document Type: Article

References (53)

1. Willcox J.K., Ash S.L., and Catignani G.L. Antioxidants and prevention of chronic disease. Clin Rev Food Sci Nutr 44 (2004) 275
2. Meydani M. Vitamin E modulation of cardiovascular diseases. Ann N Y Acad Sci 1031 (2004) 271
3. Tucker J.M., and Townsend D.M. Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed Pharmacother 59 (2005) 380
4. Hodis H.N., Mack W.J., LaBree L., Mahrer P.R., Sevanian A., Liu C.R., et al. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106 (2002) 1453
5. Munteanu A., Zingg J.-M., and Azzi A. Anti-atherosclerotic effects of alpha-tocopherol: myth or reality?. J Cell Mol Med 8 (2004) 59
6. Omaye S.T., and Zang P. Phytochemical interactions: beta-carotene, tocopherol and ascorbic acid. In: Bidlack W.R., Omaye S.T., Meskin M.S., and Jahner D. (Eds). Phytochemicals: a new paradigm (1998), Technomic Publishing Co., Inc, Pennsylvania 53
7. Robinson I., de Serna D.G., Gutierrez A., and Schade D.S. Alpha-tocopherol in humans: an explanation of clinical trial failure. Endocr Pract 12 (2006) 576
8. Tafazoli S., Wright J.S., and O'Brien P.J. Prooxidant and antioxidant activity of vitamin E analogue and troglitazone. Chem Res Toxicol 18 (2005) 1567
9. De Pascale M.C., Bassi A.M., Patrone V., Villacorta L., Azzi A., and Zingg J.M. Increased expression of transglutaminase-1 and PPARgamma after vitamin E treatment in human keratinocytes. Arch Biochem Biophys 447 (2006) 97
10. Campbell S.E., Stone W.L., Whaley S.G., Qui M., and Krishnan K. Gamma tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma expression in SW 480 human colon cancer cell lines. BMC Cancer 3 (2003) 25
11. Hwang J., Kleinhenz D.J., Lasseque B., Griendling K.K., Dikalov S., and Hart C.M. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288 (2005) C899
12. Berger J., and Moller D.E. The mechanisms of action of PPARs. Ann Rev Med 53 (2002) 409
13. Blaschke F., Caglayan E., and Hsueh W.A. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes. Endocrinol Metab Clin North Am 35 (2006) 561
14. O'Brien M.L., Spear B.T., and Glauert H.P. Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit Rev Toxicol 35 (2005) 61
15. Kunsch C., and Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85 (1999) 753
16. Singh U., and Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 13 (2006) 129
17. Fuhrman B., Shiner M., Volkova N., and Aviram M. Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation. Free Radic Biol Med 37 (2004) 259
18. Duval C., Chinetti G., Trottein F., Frunchart J.C., and Staels B. The role of PPARs in atherosclerosis. Trends Mol Med 8 (2002) 422
19. Fang X., Weintraub N.L., Rios C.D., Chappell D.A., Zwacka R.M., Engelharrdt J.F., et al. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ Res 82 (1998) 1289
20. Hawkins B.J., Madesh M., Kirkpatrick C.J., and Fisher A.B. Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. Mol Biol Cell 18 (2007) 2002
21. Madamanchi N.R., Hakim Z.S., and Runge M.S. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J Thromb Haemost 3 (2005) 254
22. Girnun G.D., Domann F.E., Moore S.A., and Robbins M.E.C. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 16 (2002) 2793
23. Yoo H.Y., Chang M.S., and Rho H.M. Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 234 (1999) 87
24. Inoue I., Goto S., Matsunaga T., Nakajima T., Awara T., Hokari S., et al. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPAR gamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expression in primary endothelial cells. Metabolism 50 (2001) 3
25. Kim J.W., Zou Y., Yoon S., Lee J.H., Kim Y.K., Yu B.P., et al. Vascular aging: molecular modulation of the prostanoid cascade by calorie restriction. J Gerontol 59 (2004) B878
26. Nakamura Y.K., Read M.H., Elias J.W., and Omaye S.T. Oxidation of serum low-density lipoprotein (LDL) and antioxidant status in young and elderly humans. Arch Gerontol Geriatr 42 (2006) 265
27. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20 (1999) 649
28. Burge J.A., and Aust S.D. Microsomal lipid peroxidation. In: Colowick S.P., and Kaplan N.O. (Eds). Methods in enzymology Vol. 52 (1978), Academic Press, Inc, New York 302
29. OXitek. In: OXItek ZMC (Ed). TBARS assay kit (2004), Zepto Metrix Corp, Buffalo (NY) 8
30. Nishimura S., Akagi M., Yoshida K., Hayakawa S., Sawamura T., Munakata H., et al. Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-kappa B. Osteoarthr Cartil 12 (2004) 568
31. Robbesyn F., Salvayre R., and Negre-Salvayre A. Dual role of oxidized LDL on the NF-kappa B signaling pathway. Free Radic Res 38 (2004) 541
32. Driessler F., Venstrom K., Sabat R., Asadullah K., and Schottelius A.J. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappa B activity: a role for p50. Clin Exp Immunol 135 (2004) 64
33. Napoli C., de Nigris F., and Palinski W. Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem 82 (2001) 674
34. Matthews J.R., Kaszubska W., Turcatti G., Wells T.N.C., and Hay R.T. Role of cycteine62 in DNA recognition by the p50 subunit of NF-kappaB. Nucleic Acids Res 21 (1993) 1727
35. Muller C.W., Rey F.A., Sodeoka M., Verdine G.L., and Harrison S.C. Structure of the NF-kappaB p50 homodimer bound to DNA. Nature 373 (1995) 311
36. Cao S., Zhang X., Edwards J.P., and Mosser D.M. NF-kB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 281 (2006) 26041
37. Wessells J., Baer M., Young H.A., Claudio E., Brown K., Siebenlist U., et al. Bcl-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem 279 (2004) 49995
38. Kuwata H., Watanabe Y., Miyoshi H., Yamamoto M., Kaisho T., Takeda K., et al. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-a production in macrophages. Blood 102 (2003) 4123
39. Iwakiri Y., Sampson D.A., and Allen K.G. Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages. Prostaglandins Leukot Essent Fat Acids 67 (2002) 435
40. Ohga S., Shikata K., Yozai K., Okada S., Ogawa D., Usui H., et al. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. Am J Physiol Renal Physiol 292 (2006) F1141
41. Lee K.S., Kim S.R., Park S.J., Park H.S., Min K.H., Jin S.M., et al. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. J Allergy Clin Immunol 118 (2006) 120
42. Tedgui A., and Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 88 (2001) 877
43. Su C.G., Wen X., Baliey S.T., Jiang W., Rangwala S.M., Keillbaugh S.A., et al. A novel therapy for colitis utilizing PPARgamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 104 (1999) 383
44. Faraci F.M. Vascular protection. Stroke 34 (2003) 327
45. Zhao X., Zhang Y., Strong R., Grotta J.C., and Aronowski J. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunctions, and neuronal loss after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab 26 (2003) 811
46. Chen K., Thomas S.R., and Keaney Jr. J.F. Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic Biol Med 35 (2003) 117
47. Woollard K.J., Rayment S.J., Bevan R., Shaw J.A., Lunec J., and Griffiths H.R. Alpha-tocopherol supplementation does not affect monocyte endothelial adhesion or C-reactive protein levels but reduces soluble vascular adhesion molecule-1 in the plasma of healthy subjects. Redox Rep 11 (2006) 214
48. Thangapazham R.L., Sharma A., and Maheshwari R.K. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 8 (2006) E443
49. Csiszar A., Smith K., Labinskyy N., Orosz Z., Rivera A., and Ungvari Z. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappa B inhibition. Am J Physiol Heart Circ Physiol 291 (2006) H1694
50. Sharma S., Dewald O., Adrogue J., Salazar R.L., Razeghi P., Crapo J.D., et al. Induction of antioxidant gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species. Free Radic Biol Med 40 (2006) 2223
51. Janeway Jr. C.A., Travers P., Walport M., and Shlomchik M.J. Innate immunity. In: Janeway Jr. C.A., Travers P., Walport M., and Shlomchik M.J. (Eds). Immunobiology. 6th ed. (2005), Garland Science, New York 37
52. Nakamura Y.K., and Omaye S.T. Age-related changes of serum lipoprotein oxidation in rats. Life Sci 74 (2004) 1265
53. Chen X., Touyz R.M., Park J.B., and Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38 (2001) 606